Welcome to precisionFDA

Welcome to PrecisionFDA

A community platform for NGS assay evaluation and regulatory science exploration.

The security of precisionFDA users’ personal information and data is of critical importance. In order to further strengthen the safeguards already in place, precisionFDA will be introducing several changes in order to achieve compliance with the FedRAMP and FISMA security standards. Please click here for more information.

Expert Spotlight:
Eaton
Dupuytren Biomarker Research: Crowdsourcing and Citizen Scientists


Charles Eaton
Dupuytren Research Group

*Dupuytren disease* is a chronic progressive disorder affecting tens of millions worldwide. Dupuytren can produce bent finger deformities of *Dupuytren contracture*, a thickening and tightening of the underlying hand tissue. Dupuytren contractures are treated with corrective procedures, but the underlying biology persists, and recurrence is common. Retreatments have greater risk and less success . There is no proven preventive treatment for early disease. Dupuytren disease is a *fibrotic systems biology disorder* [multi-system disorder that causes the formation of excess fibrous connective tissue]. It involves genetic, immune, age, inflammation, gender, mechanobiology [mechanical inputs regulate cell behavior], and epigenetic pathways. It is associated with a variety of other medical disorders and increased risk of malignant tumors. Dupuytren biology can affect hands, feet, penis, and shoulders. Despite this, the overwhelming focus of Dupuytren research remains on the anatomy and correction of Dupuytren-related finger deformities rather than the root biology. Crowdsourcing [the practice of soliciting voluntary contributions from a group of individuals or organizations] is a promising approach for advancing Dupuytren biology research due to the clear scientific benefits it provides including strengthening existing communities of researchers and clinicians, expanding the scientific participation by engaging new organizations and individuals, and providing an additional source of innovation. The number of publications on Dupuytren biology reflects this narrow focus. [read more at the full blog]

precisionFDA Challenges
Engage and improve NGS software through community challenges
Latest precisionFDA News
Learn about the latest precisionFDA events and news
Community Participants
Personalis
Seracare
Sequenom
Emory Genetics Lab
Roche
NIH
Broad Institute
DNAnexus
Edico Genome
Macrogen
Human Longevity Inc.
Crystal Genetics
Illumina
23andMe
GeneDx
NIST
White House Office of Science and Technology Policy
American Heart Association
Baylor College of Medicine
Garvan
US House of Representatives
Natera
PharmGKB
Qiagen
Counsyl
Intel
Blueprint Genetics
Centers for Disease Control and Prevention

Dr. Lester Carter
Dr. Euan Ashley
Dr. Teri Klein
Dr. Dennis P. Wall
Rachel Goldfeder
Hans Nelsen
Dr. Russ Altman
Dr. Peter Tonellato
Mark Woon
Dr. Snehit Prabhu
Dr. Mark Wright

The comparison framework uses open-source software by Real Time Genomics
Learn more about precisionFDA
Feedback Feedback